Status:
COMPLETED
Corticosteroids in Severe COVID-19 (ASAP-ESICM/ESAIC Study)
Lead Sponsor:
Brno University Hospital
Collaborating Sponsors:
European Society of Intensive Care Medicine
European Society of Anaesthesiology and Intensive Care
Conditions:
Severe COVID-19
Eligibility:
All Genders
18-100 years
Brief Summary
Brief Summary: Administration of systemic corticosteroids for patients with severe forms of severe acute respiratory syndrome in coronavirus-2 (SARS-CoV-2) infection are recommended by several guideli...
Detailed Description
Brief Summary: Administration of systemic corticosteroids for patients with severe forms of SARS-CoV-2 infection are recommended by several guidelines. In the very beginning of SARS-CoV-2 pandemic the...
Eligibility Criteria
Inclusion
- Members of European Society of Intensive Care (ESICM)
- Members of European Society of Anaesthesiology and Intensive Care (ESAIC)
Exclusion
- not members of European Society of Intensive Care (ESICM)
- not members of European Society of Anaesthesiology and Intensive Care (ESAIC)
Key Trial Info
Start Date :
May 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
466 Patients enrolled
Trial Details
Trial ID
NCT04866082
Start Date
May 30 2021
End Date
June 30 2022
Last Update
February 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brno University Hospital
Brno, South Moravian, Czechia, 62500